New Trends in Anti-Atherosclerotic Agents

Authors: Napoli, C.1; Sica, V.2; Pignalosa, O.3; Nigris, F. d.4

Source: Current Medicinal Chemistry, Volume 12, Number 15, July 2005 , pp. 1755-1772(18)

Publisher: Bentham Science Publishers

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

New approaches to atherosclerosis-related diseases include novel uses of proven treatments and development of innovative agents. Several commonly used cardiovascular drugs such as dihydropyridine calcium antagonists, ACE inhibitors containing the sulphydryl group, or highly lipophilic beta-blockers have some antiatherosclerotic activities. Moreover, new clinical trials suggesting that additional reduction of lowdensity lipoprotein cholesterol levels with statin therapy results in additional benefit in coronary heart disease prevention. Notably, new cholesterol transport or bile acid transport inhibitors have been found to produce significant reductions in intestinal cholesterol absorption and experimental atherosclerosis. Inhibitors of acyl coenzyme A:cholesterol acyltransferase, which can reduce cholesterol storage in macrophages and in arterial lesions, have also been developed. Finally, newer therapeutical strategies against atherogenesis may include the use of antioxidants and cholestyramine during pregnancy or the development of metalloproteinase inhibitors.

Keywords: atherosclerosis; statins; ace-inhibitors; antioxidants

Document Type: Review article

DOI: 10.2174/0929867054367257

Affiliations: 1: Department of General Pathology, School of Medicine, Via L. De Crecchio, 7, II University of Naples, Naples 80134, Italy or at the Evans Department of medicine and Whitaker Cardiovascular Institute, Boston University, 715 Albany St., Boston, MA 0 2: Department of General Pathology, School of Medicine, Via L. De Crecchio, 7, II University of Naples, Naples 80134, Italy or at the Evans Department of medicine and Whitaker Cardiovascular Institute, Boston University, 715 Albany St., Boston, MA 0 3: Department of General Pathology, School of Medicine, Via L. De Crecchio, 7, II University of Naples, Naples 80134, Italy or at the Evans Department of medicine and Whitaker Cardiovascular Institute, Boston University, 715 Albany St., Boston, MA 0 4: Department of General Pathology, School of Medicine, Via L. De Crecchio, 7, II University of Naples, Naples 80134, Italy or at the Evans Department of medicine and Whitaker Cardiovascular Institute, Boston University, 715 Albany St., Boston, MA 0

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$55.10 plus tax

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A